Global Autoimmune Disease Diagnostics Market to Surpass USD 16 Billion By 2025

April 20, 2020


According to the research report titled ‘Autoimmune Disease Diagnostics Market Size by Product, Industry Analysis Report, Regional Outlook Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, global autoimmune disease diagnostics market is expected to cross USD 16 billion by the year 2025.
 

Increased pervasiveness of localized and systemic autoimmune diseases is a major factor driving the growth of autoimmune disease diagnostics industry. According to AARDA (American Autoimmune Related Diseases Association), around 50 million Americans suffer from autoimmune disorders currently and the numbers are expected to surge in the forthcoming years. It also claimed that the disease primarily occurs in women and the prevalence is 75% more than men. Surging investments towards healthcare infrastructure along with shifting focus towards reducing the mortality rates associated with autoimmune diseases is aiding the market expansion. 
 

Based on the product landscape, localized autoimmune disease diagnostics market segment held 66% revenue share in 2018 and is anticipated to witness similar growth in the forthcoming years. Growing demand for diagnostic kits owing to high occurrence of anemia, type 1 diabetes and Hashimoto’s thyroiditis is fueling the segmental growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/467753/
 

Alternatively, systemic autoimmune disease diagnostics market segment is presumed to expand with a CAGR of 3.9% during 2019-2025. Development of multiple autoantibodies screen tests has allowed for early diagnosis and treatment of systemic disorders, in turn stimulating the industry outlook.
 

As per the regional analysis, U.S. autoimmune disease diagnostics industry was worth USD 5,003 million in 2018 and will continue to grow, primarily due to escalating healthcare expenditure, increasing awareness regarding autoimmune disease diagnostic devices and high concentration of advanced healthcare facilities.
 

bioMerieux SA, Inova Diagnostics Inc., AESKU Diagnostics, EUROIMMUN, Bio-Rad Laboratories Inc., SQI Diagnostics, Quest Diagnostics, Beckman Coulter Inc., Siemens AG and Abbott Laboratories are some eminent companies in worldwide autoimmune disease diagnostics industry.


Frequently Asked Questions (FAQ) :

Increased pervasiveness of localized and systemic autoimmune diseases is a major factor driving the growth of autoimmune disease diagnostics industry.
Escalating healthcare expenditure, increasing awareness regarding autoimmune disease diagnostic devices and high concentration of advanced healthcare facilities are facilitating the business scenario in the U.S.
Bio-Rad Laboratories Inc., SQI Diagnostics, Quest Diagnostics, Beckman Coulter Inc., Siemens AG and Abbott Laboratories are some eminent companies in autoimmune disease diagnostics market.